← Evidence map

ReviewTherapeutics and clinical risk management2019

Rivaroxaban in atrial fibrillation cardioversion: an update.

Carlo Lavalle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2019
2020
2021
2022
2023
2024
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 31118649